Martin P. Szuba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin P. Szuba has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Adelita Segovia
1 shared publicationAlexis Llewellyn
1 shared publicationAmy Hostetter
1 shared publicationAndrew A. Nierenberg
1 shared publicationAndrew M. Speer
1 shared publicationAnna Sluzewska
1 shared publication
Latest Publications
- 17 August 2001
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 14 (1) , 29-36
Potential mechanisms of the sleep therapies for depression
Sleep deprivation for one night has been investigated as a treatment for depression since the first publications describing its antidepressant properties almost 30 years ago [Pflug and Tolle, 1971: Int Pharmacopsychiatry 6:187–196]. It remains a field of active research. It is the only intervention consistently demonstrated to produce next‐day antidepressant results. This makes sleep deprivation an exciting and unique tool to study the pathophysiology of depressive disorders and to formulate targets for novel antidepressant agents. Importantly, it is also an effective, but underused, clinical treatment for unipolar and bipolar depression. Depression and Anxiety 14:29–36, 2001.
- 17 August 2001
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 14 (1) , 29-36
Potential mechanisms of the sleep therapies for depression
Sleep deprivation for one night has been investigated as a treatment for depression since the first publications describing its antidepressant properties almost 30 years ago [Pflug and Tolle, 1971: Int Pharmacopsychiatry 6:187–196]. It remains a field of active research. It is the only intervention consistently demonstrated to produce next‐day antidepressant results. This makes sleep deprivation an exciting and unique tool to study the pathophysiology of depressive disorders and to formulate targets for novel antidepressant agents. Importantly, it is also an effective, but underused, clinical treatment for unipolar and bipolar depression. Depression and Anxiety 14:29–36, 2001.
- Open Access
- 28 June 2001
- Published by Cambridge University Press (CUP)
Treatment-Resistant Mood Disorders
While antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, so they have had to make difficult decisions about treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation and treatment. This timely book will be invaluable to clinicians, neuroscientists, researchers and graduate students.
- 28 June 2001
- Published by Cambridge University Press (CUP)
Open AccessTreatment-Resistant Mood Disorders
While antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, so they have had to make difficult decisions about treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation and treatment. This timely book will be invaluable to clinicians, neuroscientists, researchers and graduate students.
- 1 January 2000
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 12 (3) , 170-177
Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression
Major depressive episodes are associated with dysregulation of various physiologic systems. Antidepressant medications alter regulation of the hormonal and sleep systems. A thorough understanding of these changes may elucidate the pathophysiologic basis of the disorder [Amsterdam et al., 1989: Psychoneuroendocrinology 14:43–62], and interventions targeted directly at these systems are being increasingly recognized as possible treatments for depression [Wong et al., 2000: Proc Natl Acad Sci USA 97:325–330; Szuba et al., 1996: Proc Am Coll Neuropsychopharmacol Ann Meet]. These physiologic systems are regulated by the major neurotransmitters implicated in the etiology of mood disorders—norepinephrine, serotonin, and dopamine. Many of the hormones of import for this article also act as neurotransmitters and thus alter cerebral activity themselves [Owens and Nemeroff, 1993: Ciba Found Symp 172:296–308; Weitzner, 1998: Psychother Psychosom 67:125–132]. Parenteral infusion of hydrocortisone [DeBattista, 2000: Am J Psychiatry 157:1334–1337] and thyrotropin‐releasing hormone (TRH) [Prange et al., 1972: Lancet 2:999–1002; Marangell et al., 1997: Arch Gen Psychiatry 54:214–222; Szuba, 1996: Proc Am Coll Neuropsychopharmacol Ann Meet.] produce acute antidepressant effects. Antagonists to corticotropin‐releasing hormone and repeated parenteral infusion of TRH may have antidepressant activity when given during several weeks [Wong, 2000: Proc Natl Acad Sci USA 97:325–330; Arborelius et al., 1999: J Endocrinol 160:1–12; Callahan et al., 1997: Biol Psychiatry 41:264–272]. Manipulations of the sleep system through sleep deprivation can ameliorate depression [Szuba et al., 1994: Psychiatry Res 51:283–295; see Wirz‐Justice et al., 1999: Biol Psychiatry 46:445–453 for review]. Sleep deprivation has been shown in more than three dozen studies published in the last three decades to produce marked, acute antidepressant effects in the majority of depressed individuals [Wirz‐Justice, et al., 1999: Biol Psychiatry 46:445–453]. Thus, examination of the effects the two nonpharmacologic treatments, electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), produce in these physiologic systems may help elucidate their mechanisms of action, while enhancing understanding of the neurobiology of depressive illness. We will review these physiologic changes associated with depression, the effects that manipulations of these systems can have on depressive disorders, and then describe the effects the two techniques that can stimulate the human brain in vivo, ECT and TMS, exert on these systems. Depression and Anxiety 12:170–177, 2000.
- 1 January 2000
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 12 (3) , 170-177
Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression
Major depressive episodes are associated with dysregulation of various physiologic systems. Antidepressant medications alter regulation of the hormonal and sleep systems. A thorough understanding of these changes may elucidate the pathophysiologic basis of the disorder [Amsterdam et al., 1989: Psychoneuroendocrinology 14:43–62], and interventions targeted directly at these systems are being increasingly recognized as possible treatments for depression [Wong et al., 2000: Proc Natl Acad Sci USA 97:325–330; Szuba et al., 1996: Proc Am Coll Neuropsychopharmacol Ann Meet]. These physiologic systems are regulated by the major neurotransmitters implicated in the etiology of mood disorders—norepinephrine, serotonin, and dopamine. Many of the hormones of import for this article also act as neurotransmitters and thus alter cerebral activity themselves [Owens and Nemeroff, 1993: Ciba Found Symp 172:296–308; Weitzner, 1998: Psychother Psychosom 67:125–132]. Parenteral infusion of hydrocortisone [DeBattista, 2000: Am J Psychiatry 157:1334–1337] and thyrotropin‐releasing hormone (TRH) [Prange et al., 1972: Lancet 2:999–1002; Marangell et al., 1997: Arch Gen Psychiatry 54:214–222; Szuba, 1996: Proc Am Coll Neuropsychopharmacol Ann Meet.] produce acute antidepressant effects. Antagonists to corticotropin‐releasing hormone and repeated parenteral infusion of TRH may have antidepressant activity when given during several weeks [Wong, 2000: Proc Natl Acad Sci USA 97:325–330; Arborelius et al., 1999: J Endocrinol 160:1–12; Callahan et al., 1997: Biol Psychiatry 41:264–272]. Manipulations of the sleep system through sleep deprivation can ameliorate depression [Szuba et al., 1994: Psychiatry Res 51:283–295; see Wirz‐Justice et al., 1999: Biol Psychiatry 46:445–453 for review]. Sleep deprivation has been shown in more than three dozen studies published in the last three decades to produce marked, acute antidepressant effects in the majority of depressed individuals [Wirz‐Justice, et al., 1999: Biol Psychiatry 46:445–453]. Thus, examination of the effects the two nonpharmacologic treatments, electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), produce in these physiologic systems may help elucidate their mechanisms of action, while enhancing understanding of the neurobiology of depressive illness. We will review these physiologic changes associated with depression, the effects that manipulations of these systems can have on depressive disorders, and then describe the effects the two techniques that can stimulate the human brain in vivo, ECT and TMS, exert on these systems. Depression and Anxiety 12:170–177, 2000.